{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:35:39Z","timestamp":1761849339928,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,14]],"date-time":"2022-06-14T00:00:00Z","timestamp":1655164800000},"content-version":"vor","delay-in-days":378,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100011949","name":"Abbott Vascular","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011949","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.jcin.2021.04.012","type":"journal-article","created":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T16:57:37Z","timestamp":1620838657000},"page":"1254-1256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treatment Goals for Transcatheter Edge-to-Edge Mitral Valve Repair"],"prefix":"10.1016","volume":"14","author":[{"given":"Rebecca T.","family":"Hahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcin.2021.04.012_bib1","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1056\/NEJMoa1806640","article-title":"Transcatheter mitral-valve repair in patients with heart failure","volume":"379","author":"Stone","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2021.04.012_bib2","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1056\/NEJMoa1805374","article-title":"Percutaneous repair or medical treatment for secondary mitral regurgitation","volume":"379","author":"Obadia","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcin.2021.04.012_bib3","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jacc.2020.07.010","article-title":"Predictors of clinical response to transcatheter reduction of secondary mitral regurgitation: the COAPT trial","volume":"76","author":"Grayburn","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2021.04.012_bib4","first-page":"742","article-title":"Impact of mitral regurgitation severity and left ventricular remodeling on outcome after MitraClip implantation: results from the Mitra-FR trial","volume":"14","author":"Messika-Zeitoun","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.04.012_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamacardio.2020.7200","article-title":"Association of effective regurgitation orifice area to left ventricular end-diastolic volume ratio with transcatheter mitral valve repair outcomes: a secondary analysis of the COAPT trial","volume":"6","author":"Lindenfeld","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jcin.2021.04.012_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4244\/EIJ-D-19-01114","article-title":"Impact of disproportionate secondary mitral regurgitation in patients undergoing edge-to-edge percutaneous mitral valve repair","volume":"16","author":"Adamo","year":"2020","journal-title":"EuroIntervention"},{"key":"10.1016\/j.jcin.2021.04.012_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1093\/ehjci\/jez073","article-title":"MITRA-FR vs. COAPT: lessons from two trials with diametrically opposed results","volume":"20","author":"Pibarot","year":"2019","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.jcin.2021.04.012_bib8","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.jacc.2015.05.049","article-title":"Clinical trial design principles and endpoint definitions for transcatheter mitral valve repair and replacement: part 2: endpoint definitions: a consensus document from the mitral valve academic research consortium","volume":"66","author":"Stone","year":"2015","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2021.04.012_bib9","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/eurheartj\/ehv627","article-title":"One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry","volume":"37","author":"Puls","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jcin.2021.04.012_bib10","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ahj.2015.04.010","article-title":"Predictors of clinical outcomes after edge-to-edge percutaneous mitral valve repair","volume":"170","author":"Capodanno","year":"2015","journal-title":"Am Heart J"},{"key":"10.1016\/j.jcin.2021.04.012_bib11","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1136\/heartjnl-2012-303105","article-title":"Predictors for efficacy of percutaneous mitral valve repair using the MitraClip system: the results of the MitraSwiss registry","volume":"99","author":"S\u00fcrder","year":"2013","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2021.04.012_bib12","first-page":"609","article-title":"Residual mitral valve regurgitation after percutaneous mitral valve repair with the MitraClip\u00ae system is a risk factor for adverse one-year outcome","volume":"81","author":"Paranskaya","year":"2013","journal-title":"Catheter Cardiovasc Interv"},{"key":"10.1016\/j.jcin.2021.04.012_bib13","first-page":"768","article-title":"Impact of right ventricular dysfunction on outcomes after transcatheter edge-to-edge repair for secondary mitral regurgitation","volume":"14","author":"Karam","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.04.012_bib14","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jcin.2021.03.050","article-title":"Impact of residual mitral regurgitation on survival after transcatheter edge-to-edge repair for secondary mitral regurgitation","volume":"14","author":"Higuchi","year":"2021","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.jcin.2021.04.012_bib15","article-title":"Disproportionate secondary mitral regurgitation: myths, misconceptions and clinical implications","author":"Grayburn","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.jcin.2021.04.012_bib16","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1001\/jamacardio.2019.6235","article-title":"Disproportionate emphasis on proportionate mitral regurgitation-are there better measures of regurgitant severity?","volume":"5","author":"Hahn","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"Suppl 1","key":"10.1016\/j.jcin.2021.04.012_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0735-1097(20)31845-3","article-title":"Predictors of death or heart failure hospitalization in patients with functional mitral regurgitation: sub-analysis from the COAPT trial","volume":"75","author":"Shah","year":"2020","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2021.04.012_bib18","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.echo.2017.01.007","article-title":"Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography","volume":"30","author":"Zoghbi","year":"2017","journal-title":"J\u00a0Am Soc Echocardiogr"},{"key":"10.1016\/j.jcin.2021.04.012_bib19","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1093\/ejechocard\/jeq031","article-title":"European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease)","volume":"11","author":"Lancellotti","year":"2010","journal-title":"Eur J Echocardiogr"},{"key":"10.1016\/j.jcin.2021.04.012_bib20","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jacc.2020.11.035","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jcin.2021.04.012_bib21","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease: the Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879821007111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879821007111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T18:14:14Z","timestamp":1761848054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879821007111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":21,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S1936879821007111"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2021.04.012","relation":{},"ISSN":["1936-8798"],"issn-type":[{"type":"print","value":"1936-8798"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment Goals for Transcatheter Edge-to-Edge Mitral Valve Repair","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2021.04.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2021.03.050","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the American College of Cardiology Foundation. Published by Elsevier.","name":"copyright","label":"Copyright"}]}}